Use of two separate pattern recognition receptor (PRR) agonists as adjuvants in vaccine formulations has shown to enhance the immune response against the antigen. The limitation with the use of two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback